Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke (Q34017153)

From Wikidata

Jump to navigation Jump to search

scientific article

Language	Label	Description	Also known as
English	Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke	scientific article

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Recombinant T cell receptor ligand treatment improves neurological outcome in the presence of tissue plasminogen activator in experimental ischemic stroke (English)

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

1 reference

based on heuristic

inferred from title

5

object named as

Halina Offner

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

author name string

Wenbin Zhu

1

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Nicole L Libal

2

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Amanda Casper

3

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Sheetal Bodhankar

4

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Nabil J Alkayed

6

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

publication date

24 June 2014

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Translational stroke research

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

5

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

612-617

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

https://scigraph.springernature.com/pub.10.1007/s12975-014-0348-8

0 references

Stroke treatment academic industry roundtable: research priorities in the assessment of neurothrombectomy devices

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Role of endothelial soluble epoxide hydrolase in cerebrovascular function and ischemic injury.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Rationally designed mutations convert complexes of human recombinant T cell receptor ligands into monomers that retain biological activity.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

An activated protein C analog with reduced anticoagulant activity extends the therapeutic window of tissue plasminogen activator for ischemic stroke in rodents.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Stroke Treatment Academic Industry Roundtable (STAIR) recommendations for maximizing the use of intravenous thrombolytics and expanding treatment options with intra-arterial and neuroprotective therapies

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Ischaemic stroke: a thrombo-inflammatory disease?

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Thrombin mutant W215A/E217A treatment improves neurological outcome and reduces cerebral infarct size in a mouse model of ischemic stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Therapy with recombinant T-cell receptor ligand reduces infarct size and infiltrating inflammatory cells in brain after middle cerebral artery occlusion in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Characterization of human platelet binding of recombinant T cell receptor ligand.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Recanalization and reperfusion in acute ischemic stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Isoflurane preconditioning neuroprotection in experimental focal stroke is androgen-dependent in male mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Recombinant T cell receptor ligand treats experimental stroke

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Effect of experimental stroke on peripheral immunity: CNS ischemia induces profound immunosuppression

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Inflammation and ischaemic stroke.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Lymphocytes: potential mediators of postischemic injury and neuroprotection.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Stroke-induced immunodepression: experimental evidence and clinical relevance

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Inflammation following stroke.

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Recommendations for standards regarding preclinical neuroprotective and restorative drug development

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Recombinant tissue plasminogen activator reduces infarct size after reversible thread occlusion of middle cerebral artery in mice

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Two receptor systems are involved in the plasma clearance of tissue-type plasminogen activator (t-PA) in vivo

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4125526

5 July 2018

Splenic atrophy in experimental stroke is accompanied by increased regulatory T cells and circulating macrophages.

1 reference

https://api.crossref.org/works/10.1007%2FS12975-014-0348-8

21 January 2018

Recombinant TCR ligand induces early TCR signaling and a unique pattern of downstream activation

1 reference

https://api.crossref.org/works/10.1007%2FS12975-014-0348-8

21 January 2018

Recombinant TCR ligand induces tolerance to myelin oligodendrocyte glycoprotein 35-55 peptide and reverses clinical and histological signs of chronic experimental autoimmune encephalomyelitis in HLA-DR2 transgenic mice

1 reference

https://api.crossref.org/works/10.1007%2FS12975-014-0348-8

21 January 2018

Enhanced cortical reperfusion protects coagulation factor XII-deficient mice from ischemic stroke as revealed by high-field MRI.

1 reference

https://api.crossref.org/works/10.1007%2FS12975-014-0348-8

21 January 2018

Reperfusion of cerebral artery thrombosis by the GPIb-VWF blockade with the Nanobody ALX-0081 reduces brain infarct size in guinea pigs

1 reference

https://api.crossref.org/works/10.1007%2FS12975-014-0348-8

21 January 2018

Lack of secondary microthrombosis after thrombin-induced stroke in mice and non-human primates.

1 reference

https://api.crossref.org/works/10.1007%2FS12975-014-0348-8

21 January 2018

Human leukocyte antigen-DRB1*1502 (DR2Dw12) transgene reduces incidence and severity of arthritis in mice

1 reference

https://pubmed.ncbi.nlm.nih.gov/24953050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design, engineering and production of functional single-chain T cell receptor ligands

1 reference

https://pubmed.ncbi.nlm.nih.gov/24953050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Design, engineering, and production of human recombinant t cell receptor ligands derived from human leukocyte antigen DR2

1 reference

https://pubmed.ncbi.nlm.nih.gov/24953050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Experimental stroke induces massive, rapid activation of the peripheral immune system

1 reference

https://pubmed.ncbi.nlm.nih.gov/24953050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Clearance of tissue plasminogen activator (TPA) and TPA/plasminogen activator inhibitor type 1 (PAI-1) complex: relationship to elevated TPA antigen in patients with high PAI-1 activity levels

1 reference

https://pubmed.ncbi.nlm.nih.gov/24953050

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12975-014-0348-8

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

Dimensions Publication ID

0 references

PMC publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

30 July 2017

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q34017153&oldid=1972074776"